Filed: 2/17/2026ACC: 0002077247-26-000002
📋 What this filing means
TRAILS EDGE CAPITAL PARTNERS, LP filed this quarterly 13F‑HR report disclosing 23 equity positions with a total reported market value of $404.74M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
23
Positions
$404.74M
Total AUM (reported)
28.90M
Total Shares
Allocation by class
COM$271.04M67.0%
COM NEW$57.34M14.2%
ADS$36.05M8.9%
COM SHS$31.07M7.7%
CL A NEW$9.24M2.3%
Portfolio Concentration
Top 3$106.33M26.3%
4–10$171.00M42.2%
11–25$127.41M31.5%
Top 3 weight
26.3%
Top 10 weight
68.5%
Voting Authority Distribution
Total shares with voting rights: 28.90M
Sole
Full voting authority
28.90M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole23
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings23
Rows:
ACADIA PHARMACEUTICALS INC
SOLEShares1.42M
TypeSH
Market value$37.91M
9.37%
Sole
1.42M
Shared
0.00
None
0.00
MIND MEDICINE MINDMED INC
SOLEShares2.57M
TypeSH
Market value$34.39M
8.50%
Sole
2.57M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares737.47K
TypeSH
Market value$34.03M
8.41%
Sole
737.47K
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares1.74M
TypeSH
Market value$33.07M
8.17%
Sole
1.74M
Shared
0.00
None
0.00
LB PHARMACEUTICALS INC
SOLEShares1.40M
TypeSH
Market value$31.07M
7.68%
Sole
1.40M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares597.09K
TypeSH
Market value$26.76M
6.61%
Sole
597.09K
Shared
0.00
None
0.00
IMMUNOCORE HLDGS PLC
SOLEShares682.60K
TypeSH
Market value$23.69M
5.85%
Sole
682.60K
Shared
0.00
None
0.00
ARCUS BIOSCIENCES INC
SOLEShares916.31K
TypeSH
Market value$21.84M
5.40%
Sole
916.31K
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares700K
TypeSH
Market value$18.40M
4.55%
Sole
700K
Shared
0.00
None
0.00
NEUROGENE INC
SOLEShares785K
TypeSH
Market value$16.17M
4.00%
Sole
785K
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares1.04M
TypeSH
Market value$14.86M
3.67%
Sole
1.04M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares192K
TypeSH
Market value$14.49M
3.58%
Sole
192K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares6.18M
TypeSH
Market value$12.67M
3.13%
Sole
6.18M
Shared
0.00
None
0.00
INVENTIVA SA
SOLEShares2.66M
TypeSH
Market value$12.36M
3.05%
Sole
2.66M
Shared
0.00
None
0.00
CAMP4 THERAPEUTICS CORP
SOLEShares1.98M
TypeSH
Market value$12.16M
3.00%
Sole
1.98M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares300K
TypeSH
Market value$12.12M
2.99%
Sole
300K
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares2.57M
TypeSH
Market value$10.29M
2.54%
Sole
2.57M
Shared
0.00
None
0.00
MBX BIOSCIENCES INC
SOLEShares315.16K
TypeSH
Market value$9.94M
2.46%
Sole
315.16K
Shared
0.00
None
0.00
VTV THERAPEUTICS INC
SOLEShares231K
TypeSH
Market value$9.24M
2.28%
Sole
231K
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares1.42M
TypeSH
Market value$7.60M
1.88%
Sole
1.42M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares240.16K
TypeSH
Market value$6.10M
1.51%
Sole
240.16K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares199.31K
TypeSH
Market value$3.07M
0.76%
Sole
199.31K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares31.86K
TypeSH
Market value$2.52M
0.62%
Sole
31.86K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ACADIA PHARMACEUTICALS INCSOLE | COM | 1.42M | SH | $37.91M 9.37% | 1.42M | 0.00 | 0.00 |
MIND MEDICINE MINDMED INCSOLE | COM NEW | 2.57M | SH | $34.39M 8.50% | 2.57M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 737.47K | SH | $34.03M 8.41% | 737.47K | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 1.74M | SH | $33.07M 8.17% | 1.74M | 0.00 | 0.00 |
LB PHARMACEUTICALS INCSOLE | COM SHS | 1.40M | SH | $31.07M 7.68% | 1.40M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 597.09K | SH | $26.76M 6.61% | 597.09K | 0.00 | 0.00 |
IMMUNOCORE HLDGS PLCSOLE | ADS | 682.60K | SH | $23.69M 5.85% | 682.60K | 0.00 | 0.00 |
ARCUS BIOSCIENCES INCSOLE | COM | 916.31K | SH | $21.84M 5.40% | 916.31K | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COM | 700K | SH | $18.40M 4.55% | 700K | 0.00 | 0.00 |
NEUROGENE INCSOLE | COM | 785K | SH | $16.17M 4.00% | 785K | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 1.04M | SH | $14.86M 3.67% | 1.04M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 192K | SH | $14.49M 3.58% | 192K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 6.18M | SH | $12.67M 3.13% | 6.18M | 0.00 | 0.00 |
INVENTIVA SASOLE | ADS | 2.66M | SH | $12.36M 3.05% | 2.66M | 0.00 | 0.00 |
CAMP4 THERAPEUTICS CORPSOLE | COM | 1.98M | SH | $12.16M 3.00% | 1.98M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 300K | SH | $12.12M 2.99% | 300K | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM NEW | 2.57M | SH | $10.29M 2.54% | 2.57M | 0.00 | 0.00 |
MBX BIOSCIENCES INCSOLE | COM | 315.16K | SH | $9.94M 2.46% | 315.16K | 0.00 | 0.00 |
VTV THERAPEUTICS INCSOLE | CL A NEW | 231K | SH | $9.24M 2.28% | 231K | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 1.42M | SH | $7.60M 1.88% | 1.42M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 240.16K | SH | $6.10M 1.51% | 240.16K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 199.31K | SH | $3.07M 0.76% | 199.31K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 31.86K | SH | $2.52M 0.62% | 31.86K | 0.00 | 0.00 |